Healthcare logistics adapts to AI and access challenges

Healthcare supply chains become increasingly AI-driven

Artificial intelligence is carving out several niches in medicine, from diagnostics to drug discovery to predictive analytics. AI is not only improving clinical decision-making, it’s also beginning to impact healthcare supply chains.

What to know

• One of the earliest uses of AI in the medical setting was in diagnostics. For instance, AI-assisted imaging can quickly and accurately identify abnormalities and help detect diseases and conditions before human doctors spot them. This has been driving demand for imaging equipment and diagnostic testing kits.
• AI is also useful for developing customized treatments based on highly variable factors such as a person’s lifestyle, medical history and likelihood of experiencing adverse effects. Mass-market medications, too, are increasingly developed using AI.
• In predictive analytics, AI can identify patients at higher risk for certain diseases so they can get preventive care. Remote patient monitoring with sensors can track vital signs, detect irregularities, and alert health professionals in real-time.

What it means for healthcare supply chains

• As healthcare becomes more data-driven and predictive, the industry will increasingly need logistics services with advanced real-time visibility, rapid response, and more flexible inventory-positioning strategies.
• Personalized medicines, cell and gene therapies, and other patient-specific treatments require more tailored drug production and distribution. That is increasing demand for ultra-cold storage and transportation, strict chain of custody, and time-sensitive delivery.
• Growth in telemedicine and remote patient monitoring is accelerating direct-to-patient distribution, requiring stronger residential delivery capabilities, shipment visibility, and reverse logistics for device replacement.

Behind the rural hospital crisis

A growing number of rural hospitals are struggling financially, closing entirely, or eliminating services such as maternity care and emergency medicine. As hospitals close or cut back, patients often must travel farther for care, creating healthcare access challenges and placing additional strain on regional health systems and medical supply chains.

What to know

• During the COVID-19 pandemic, many rural hospitals relied on special federal assistance. That support has ended.
• Private insurers cover roughly half of a rural hospital’s patients. When reimbursement rates fail to keep pace with the cost of care, hospitals can struggle to remain financially viable.
• Making these at-risk hospitals profitable again would require an additional $5 billion annually. But hospital financing is largely tailored to patient traffic and patient mix in urban contexts.
• Even rural hospitals that do manage to stay afloat are cutting back on critical services. Money normally directed toward care and infrastructure improvements is now used to cover budget shortfalls.

What it means for healthcare supply chains

• Rural hospital closures are changing distribution networks. As services move to larger regional medical centers, medical supplies, pharmaceuticals, and equipment must be rerouted to reach patients and healthcare providers.
• As patients travel farther for treatment, coordinating critical supplies across a broader geographic footprint adds supply chain complexity.
• Healthcare supply chains will need greater flexibility and visibility. Demand for medical products can shift quickly between facilities. Look for a logistics provider that can enhance your inventory planning, transportation coordination, and real-time visibility to maintain service levels.

U.S. tariff changes

The latest changes to U.S. tariff policy underscore that trade compliance and customs expertise remain critical supply chain capabilities:

• Across-the-board Section 122 tariffs expired in July and were immediately replaced with Section 301 tariffs tied to screening for forced labor in supply chains. Imports from 60 countries are subject to these new tariffs, at rates of 10% or 12.5%.
• While negotiations on the U.S.-Mexico-Canada Agreement continue, Canadian goods face the threat of 50% tariffs under Section 338, which allows for additional duties when a foreign country is found to be treating U.S. commerce unfairly or discriminatorily. The implementation date is August 19, 2026.
• In retaliation for certain taxes on U.S. tech companies’ revenues, the U.S. administration has threatened 25% tariffs under Section 301 on goods from several European countries. It is currently unclear if and when these may be implemented.
• The U.S. administration announced it would levy a 100% tariff on imported generic medications starting August 1, 2028, and increasing to 200% as of August 1, 2029. For now, the supply chain impact is limited, but the proposal signals continued use of tariffs to push reshoring in strategic sectors.

To stay abreast of developments, subscribe to our Trade & Tariffs Insights.

Table of Contents